×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMRX – immuneering corporation - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
08:07 am
imrx
Immuneering Launches Pancreatic Cancer Advisory Board [Yahoo! Finance]
High
Report
Immuneering Launches Pancreatic Cancer Advisory Board [Yahoo! Finance]
12/19
08:00 am
imrx
Immuneering Launches Pancreatic Cancer Advisory Board
High
Report
Immuneering Launches Pancreatic Cancer Advisory Board
12/17
08:05 am
imrx
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025 [Yahoo! Finance]
Low
Report
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025 [Yahoo! Finance]
12/17
08:00 am
imrx
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
Low
Report
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
12/13
02:44 pm
imrx
Morgan Stanley upgrades PTC, cuts Immuneering, Amicus [Seeking Alpha]
Low
Report
Morgan Stanley upgrades PTC, cuts Immuneering, Amicus [Seeking Alpha]
12/13
08:13 am
imrx
Immuneering Co. (NASDAQ: IMRX) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating.
High
Report
Immuneering Co. (NASDAQ: IMRX) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating.
12/12
08:17 am
imrx
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma [Yahoo! Finance]
High
Report
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma [Yahoo! Finance]
12/12
08:00 am
imrx
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
Medium
Report
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2024
04:05 pm
imrx
immuneering corporation - class a
BEAT
Report
12.1%
immuneering corporation - class a
8/6/2024
04:05 pm
imrx
immuneering corporation - class a
BEAT
Report
-8.1%
immuneering corporation - class a
5/7/2024
04:05 pm
imrx
immuneering corporation - class a
MISS
Report
4.5%
immuneering corporation - class a
3/1/2024
08:00 am
imrx
immuneering corporation - class a
MISS
Report
-0.8%
immuneering corporation - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/2
04:19 pm
imrx
Form 4 Immuneering Corp For: Jan 01 Filed by: BERMAN ANN E
Low
Report
Form 4 Immuneering Corp For: Jan 01 Filed by: BERMAN ANN E
1/2
04:12 pm
imrx
Form 4 Immuneering Corp For: Jan 01 Filed by: Feinberg Peter
Low
Report
Form 4 Immuneering Corp For: Jan 01 Filed by: Feinberg Peter
1/2
04:06 pm
imrx
Form 4 Immuneering Corp For: Jan 01 Filed by: KEATING LAURIE
Low
Report
Form 4 Immuneering Corp For: Jan 01 Filed by: KEATING LAURIE
11/14
04:16 pm
imrx
Form SC 13G/A Immuneering Corp Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SC 13G/A Immuneering Corp Filed by: CITADEL ADVISORS LLC
11/14
03:04 pm
imrx
Form SC 13G/A Immuneering Corp Filed by: Cormorant Asset Management, LP
Low
Report
Form SC 13G/A Immuneering Corp Filed by: Cormorant Asset Management, LP
11/13
04:10 pm
imrx
Form 10-Q Immuneering Corp For: Sep 30
High
Report
Form 10-Q Immuneering Corp For: Sep 30
11/13
04:04 pm
imrx
Form 8-K Immuneering Corp For: Nov 13
High
Report
Form 8-K Immuneering Corp For: Nov 13
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: